Status:
UNKNOWN
New Imaging Procedures and Therapeutic Approach in Basal Cell Carcinoma Management
Lead Sponsor:
Dr. Stephanie Geisler
Conditions:
Basal Cell Carcinoma
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The aim of this study is to show that the Nd:YAG laser could be a promising alternative treatment option in the management of low-risk basal cell carcinomas with similar high efficacy rates to surgery...
Eligibility Criteria
Inclusion
- Patients with one or more basal cell carcinoma(s) on head, trunk or extremities
- Diagnosed clinically, with a dermatoscope and through noninvasive imaging methods such as reflectance confocal microscopy and optical coherence tomography
- H zone \<6mm, M zone \<10mm, L zone \<20mm
- Tumor thickness \<2mm
- Clearly visible margins
Exclusion
- Pregnancy
- \<18 years of age
- Current or history of immunosuppression
- Prior-treatment of the basal cell carcinoma/ recurrent basal cell carcinomas
- History of radiation in the area of basal cell carcinoma appearance
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05324202
Start Date
September 1 2022
End Date
April 1 2023
Last Update
April 12 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.